A professional comparison of Nexfill, Juvederm, Stylage and Kamilane
Hyaluronic acid (HA) lip fillers are among the most widely used injectables in aesthetic medicine. For clinics and medical practitioners, selecting the right product goes beyond brand recognition — it requires a precise understanding of each product’s rheological properties, HA concentration, cross-linking technology, and clinical suitability for different patient profiles.
This guide provides a technical comparison of four HA-based lip filler products available through Filler Depot: Nexfill, Juvederm, Stylage, and Kamilane. The goal is to support evidence-based product selection and improve clinical outcomes.
Why Hyaluronic Acid for Lip Augmentation?
Hyaluronic acid is the dominant substrate in lip filler procedures for several reasons. It is biocompatible, reversible via hyaluronidase, and produces predictable, controllable results. HA molecules bind water and create volume by occupying space in the dermal tissue.
The clinical performance of an HA filler is determined not only by its HA concentration but by its cross-linking density (G’ modulus), particle size, cohesivity, and the presence of lidocaine. These properties collectively define how the product integrates into tissue, how long it lasts, and how it responds to movement — a critical consideration for the dynamic lip area.
Product Overview
Nexfill Fine
Nexfill Fine is a monophasic, cross-linked hyaluronic acid filler developed for the correction of fine lines and subtle contour refinement. It is the lightest formulation in the Nexfill range and is intended for placement in the mid-dermis. The product contains 0.3% lidocaine to help reduce discomfort during injection.
Key characteristics:
- HA concentration: 24 mg/mL
- Cross-linking: BDDE (1,4-butanediol diglycidyl ether) using Nexfill’s Ultra High Density technology
- Consistency: Homogeneous monophasic HA gel
- Lidocaine: Yes, 0.3%
- Manufacturer-reported longevity: 3–6 months
- Manufacturer-listed treatment areas: Fine facial lines, periorbital lines, forehead lines, and subtle lip-contour refinement
- Recommended injection plane: Mid-dermis
Nexfill Fine is designed for treatments requiring subtle correction rather than substantial volume. Its formulation makes it suitable for fine-line correction and delicate contouring where controlled, natural-looking results are desired.ractitioners who prefer a product with low resistance during injection. Its softness makes it appropriate for fine cannula techniques.
Juvéderm Volbella and Ultra
Juvederm is one of the most established HA filler brands globally, manufactured by Allergan Aesthetics. For lip procedures, two products are most frequently used: Volbella (for subtle volume and definition) and Ultra (for more pronounced augmentation).
Key characteristics — Volbella:
- HA concentration: 15 mg/ml (Vycross technology)
- Cross-linking: Vycross (a proprietary blend of low and high molecular weight HA)
- Consistency: Low G’, highly cohesive
- Lidocaine: Yes
- Longevity: Up to 12 months
- Indicated for: Subtle lip enhancement, perioral lines, lip hydration
Key characteristics — Ultra:
- HA concentration: 24 mg/ml (Hylacross technology)
- Cross-linking: Hylacross (high molecular weight HA)
- Consistency: Higher G’, more volumizing
- Lidocaine: Yes
- Longevity: 9–12 months
- Indicated for: Significant volume increase, structural lip augmentation
Juvederm’s dual-product lip approach allows clinicians to tier treatment by desired outcome. The Vycross technology in Volbella produces a highly refined result, while Ultra delivers more substantial volume with a firmer feel.
Stylage Special Lips
Stylage, produced by Vivacy Laboratories, uses IPN-Like (Interpenetrating Polymer Network) cross-linking technology and is the only major lip filler on the European market that incorporates antioxidant mannitol in its formulation. This addition is intended to reduce oxidative stress in the tissue and may extend product longevity.
Key characteristics:
- HA concentration: 16 mg/ml
- Cross-linking: IPN-Like technology with mannitol
- Consistency: Cohesive, moderately low G’
- Lidocaine: Yes
- Longevity: 9–15 months
- Indicated for: Lip volumization, hydration, contouring
The inclusion of mannitol differentiates Stylage from competing products. Mannitol acts as a free radical scavenger, which may reduce post-injection inflammation and support longer-lasting results. For patients who experience significant swelling or rapid filler degradation, Stylage Special Lips may be a clinically justified choice.
Clinical Comparison: Key Parameters
| Parameter | Nexfill Fine | Juvederm Volbella | Juvederm Ultra | Stylage Special Lips |
| HA concentration | 24 mg/ml | 15 mg/ml | 24 mg/ml | 16 mg/ml |
| Cross-linking | BDDE | Vycross | Hylacross | IPN-Like + mannitol |
| G’ modulus | Low | Low | Moderate-high | Moderate-low |
| Lidocaine | Yes | Yes | Yes | Yes |
| Estimated longevity | 3-6 months | Up to 12 months | 9–12 months | 9–12 months |
| Antioxidant | No | No | No | Yes (mannitol) |
| Reversibility | Yes (hyaluronidase) | Yes | Yes | Yes |
Product Selection: A Clinical Decision Framework
Selecting an appropriate lip filler requires assessment of the patient’s existing lip anatomy, desired degree of augmentation, previous treatments, medical history, known sensitivities, tissue characteristics, and the product’s approved indications. The practitioner must also consider the recommended injection plane and use a technique consistent with the current instructions for use.
For Subtle Enhancement and Lip Definition
Juvéderm Volbella and Stylage Special Lips are specifically developed for subtle lip enhancement, contour definition, and hydration. Nexfill Fine may be considered for lip-contour refinement where this application is included in the current local instructions for use. Product selection should be based on the individual patient rather than whether the patient is receiving filler for the first time.
For a More Noticeable Increase in Lip Volume
Juvéderm Ultra is indicated for lip augmentation and may be considered when a more noticeable increase in volume is desired.
For Patients with Previous Reactions or Complications
No product should automatically be recommended for patients with a history of inflammatory reactions, delayed-onset nodules, hypersensitivity, vascular complications, or unusually rapid loss of correction. Although the mannitol in Stylage Special Lips has antioxidant properties, current evidence does not establish it as the preferred filler for patients with previous inflammation or rapid filler metabolism. These patients require an individual medical assessment before further treatment.
Needle and Cannula Selection
The choice between a needle and a cannula should be based on the treatment area, anatomical considerations, intended injection plane, product instructions, and practitioner training. Claims that a particular filler is inherently better suited to cannula injection require comparative injectability data. Neither a needle nor a cannula eliminates the risk of vascular complications.
Safety Considerations
HA filler treatment is a medical procedure. Common reactions include temporary swelling, bruising, redness, tenderness, pain, firmness, and lumps or bumps at the injection site. Delayed inflammatory reactions, infection, nodules, granulomas, and migration may also occur.
Unintentional injection into a blood vessel is rare but can cause vascular occlusion, tissue necrosis, visual impairment or blindness, stroke, and other serious injury. Practitioners must understand the relevant anatomy, inject slowly and with low pressure, use appropriately small amounts, monitor the tissue continuously, recognize warning signs, and maintain an up-to-date emergency protocol.
Aspiration may produce false-negative results and should not be relied upon as confirmation that the needle or cannula is outside a blood vessel. Unusual pain, blanching, skin-colour changes, or visual or neurological symptoms require immediate assessment and action.
HA fillers can generally be degraded with hyaluronidase, but the response varies and complete or immediate removal cannot be guaranteed. Practitioners should have appropriate access to hyaluronidase and be trained in current complication-management protocols.
Regulatory status must be verified for each exact product and variant. A blanket statement that every listed product is CE-marked should only be made when current declarations of conformity and CE documentation have been confirmed.
Ordering from FillerDepot
FillerDepot supplies a selection of HA fillers from Nexfill, Juvéderm, and Stylage to qualified aesthetic clinics, plastic surgeons, and medical distributors across the Nordic and Baltic markets. Product availability, regulatory status, and professional-verification requirements may vary by country.
Products should be transported and stored according to each manufacturer’s requirements. Because some HA fillers are labelled for controlled room-temperature storage, “cold-chain compliance” should not be presented as a universal product requirement.
For current availability, pricing, regulatory documentation, product samples, or ordering information, contact the FillerDepot team through fillerdepot.com.
Conclusion
Selecting an HA filler requires more than comparing brands or HA concentrations. Each product differs in its intended purpose, cross-linking technology, recommended placement, handling characteristics, and supporting clinical or manufacturer information.
Juvéderm Volbella and Stylage Special Lips are specifically positioned for subtle lip enhancement, while Juvéderm Ultra is indicated for more noticeable lip augmentation. Nexfill Fine are broader facial-filler formulations, and any use in the lips must be confirmed against the current local instructions for use.
Understanding the differences between BDDE-based Nexfill technology, Vycross, Hylacross, and IPN-Like technology—and recognizing the limitations of claims involving G′, mannitol, longevity, and injection technique—supports safer and more appropriate product selection.
FillerDepot provides access to professionally sourced HA fillers, with availability and supporting documentation determined by the applicable market and product variant.